Overview

Intradermal Acupuncture Based on Changes in Biological Specificity of Acupoints for Major Depressive Disorder

Status:
Recruiting
Trial end date:
2025-12-30
Target enrollment:
Participant gender:
Summary
Acupoints are the stimulus points and reactive points for acupuncture to treat diseases. Therefore, this study is designed to detect the pain threshold and temperature of biological specificities of acupoints in healthy control (HC) participants and major depressive disorder (MDD) participants by using pressure pain threshold gauge (PTG) and infrared thermography (IRT). Based on the results of the PTG and IRT tests, the potentially superior acupoints for the treatment of MDD will be selected separately. Then, different acupoint groups selected based on different biological specificities tests will be used for clinical treatment to evaluate the clinical efficacy of intradermal acupuncture (IA) for MDD based on changes in the biological specificities of acupoints.
Phase:
N/A
Details
Lead Sponsor:
The Third Affiliated hospital of Zhejiang Chinese Medical University
Collaborators:
First People's Hospital of Hangzhou
Zhejiang Provincial Tongde Hospital
Treatments:
Antidepressive Agents